These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2830663)

  • 1. Elevated thalamic dopamine: possible link to sensory dysfunctions in schizophrenia.
    Oke AF; Adams RN
    Schizophr Bull; 1987; 13(4):589-604. PubMed ID: 2830663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the thalamus in language: is it related to schizophrenic thought disorder?
    Crosson B; Hughes CW
    Schizophr Bull; 1987; 13(4):605-21. PubMed ID: 3326161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensory physiology and catecholamines in schizophrenia and mania.
    Adler LE; Gerhardt GA; Franks R; Baker N; Nagamoto H; Drebing C; Freedman R
    Psychiatry Res; 1990 Mar; 31(3):297-309. PubMed ID: 2333360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine.
    Joyce JN
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S16-34. PubMed ID: 7831438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.
    Clinton SM; Ibrahim HM; Frey KA; Davis KL; Haroutunian V; Meador-Woodruff JH
    Am J Psychiatry; 2005 Oct; 162(10):1859-71. PubMed ID: 16199832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects.
    Oke AF; Putz C; Adams RN; Bird ED
    Psychiatry Res; 1992 Dec; 45(4):203-8. PubMed ID: 1363335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and norepinephrine activity in schizophrenia. An integrative perspective.
    van Kammen DP; Kelley M
    Schizophr Res; 1991; 4(2):173-91. PubMed ID: 2039760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elementary neuronal dysfunctions in schizophrenia.
    Freedman R; Waldo M; Bickford-Wimer P; Nagamoto H
    Schizophr Res; 1991; 4(2):233-43. PubMed ID: 1645590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications for the thalamic reticular nucleus in impaired attention and sleep in schizophrenia.
    Young A; Wimmer RD
    Schizophr Res; 2017 Feb; 180():44-47. PubMed ID: 27510855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
    Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
    JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thalamic reticular nucleus: a functional hub for thalamocortical network dysfunction in schizophrenia and a target for drug discovery.
    Pratt JA; Morris BJ
    J Psychopharmacol; 2015 Feb; 29(2):127-37. PubMed ID: 25586397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia.
    Yasuno F; Suhara T; Okubo Y; Sudo Y; Inoue M; Ichimiya T; Takano A; Nakayama K; Halldin C; Farde L
    Am J Psychiatry; 2004 Jun; 161(6):1016-22. PubMed ID: 15169689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrative Perspective on the Role of Dopamine in Schizophrenia.
    Maia TV; Frank MJ
    Biol Psychiatry; 2017 Jan; 81(1):52-66. PubMed ID: 27452791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do we still believe in the dopamine hypothesis? New data bring new evidence.
    Abi-Dargham A
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S1-5. PubMed ID: 14972078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological markers in schizophrenia].
    Lembreghts M; Ansseau M
    Encephale; 1993; 19(5):501-23. PubMed ID: 8306920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesocortical neurotensin/dopamine system: is it involved in the pathogenesis of schizophrenia?
    Satoh K
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):503-6. PubMed ID: 1722262
    [No Abstract]   [Full Text] [Related]  

  • 18. Cortical development and thalamic pathology in schizophrenia.
    Jones EG
    Schizophr Bull; 1997; 23(3):483-501. PubMed ID: 9327511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated dopamine/norepinephrine ratios in thalami of schizophrenic brains.
    Oke AF; Adams RN; Winblad B; von Knorring L
    Biol Psychiatry; 1988 May; 24(1):79-82. PubMed ID: 3370279
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurobiological studies of sensory gating in schizophrenia.
    Freedman R; Adler LE; Gerhardt GA; Waldo M; Baker N; Rose GM; Drebing C; Nagamoto H; Bickford-Wimer P; Franks R
    Schizophr Bull; 1987; 13(4):669-78. PubMed ID: 2894074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.